601089.SS · 福元医药
China A-shares · RS rating 23 · As of 2026-10-14
| Price | 15.85 CNY |
|---|---|
| 1-day change | +0.0% |
| RS rating (overall / 1M / 3M / 12M) | 23 / 71 / 40 / 20 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 25 / 19 / 18 |
| Industry group (rank) | Medical-Generic Drugs (40) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | +10.8% |
| Distance from 52-week high | +47.6% |
| Market cap (USD) | $1.2B |